
[METH- + (PEN)ICILLIN.]
A synthetic antibiotic related to penicillin and most commonly used in treatment of infections caused by staphylococci that produce penicillinase.

| methyne, methyltransferase, methylthioribose | |
| metmyoglobin, metre, metre-kilogram-second system |
A semisynthetic penicillin which is highly resistant to inactivation by penicillinase; its sodium salt is used parenterally.
| Systematic (IUPAC) name | |
|---|---|
| (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | IV |
| Pharmacokinetic data | |
| Bioavailability | Not orally absorbed |
| Metabolism | hepatic, 20–40% |
| Half-life | 25–60 minutes |
| Excretion | renal |
| Identifiers | |
| CAS number | 61-32-5 |
| ATC code | J01CF03 QJ51CF03 |
| PubChem | CID 6087 |
| DrugBank | DB01603 |
| ChemSpider | 5862 |
| UNII | Q91FH1328A |
| ChEMBL | CHEMBL575 |
| Chemical data | |
| Formula | C17H20N2O6S |
| Mol. mass | 380.42 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Meticillin (INN, BAN) or methicillin (USAN) is a narrow-spectrum beta-lactam antibiotic of the penicillin class. It should not be confused with the antibiotic metacycline.
|
Contents
|
Methicillin was developed by Beecham in 1959.[1] It was previously used to treat infections caused by susceptible Gram-positive bacteria, in particular, beta-lactamase-producing organisms such as Staphylococcus aureus that would otherwise be resistant to most penicillins, but it is no longer clinically used.
Its role in therapy has been largely replaced by flucloxacillin and dicloxacillin, however the term methicillin-resistant Staphylococcus aureus (MRSA) continues to be used to describe Staphylococcus aureus strains resistant to all penicillins.
Methicillin is no longer manufactured because the more stable and similar penicillins such as oxacillin (used for clinical antimicrobial susceptibility testing), flucloxacillin, and dicloxacillin are used medically.
Like other beta-lactam antibiotics, methicillin acts by inhibiting the synthesis of bacterial cell walls. It inhibits cross-linkage between the linear peptidoglycan polymer chains that make up a major component of the cell wall of Gram-positive bacteria. It does this by binding to and competitively inhibiting the transpeptidase enzyme used by bacteria to cross-link the peptide (D-alanyl-alanine) used in peptidoglycan synthesis. Methicillin and other beta-lactam antibiotics are structural analogs of D-alanyl-alanine, and the transpeptidase enzymes that bind to them are sometimes called penicillin-binding proteins (PBPs). [2]
Methicillin is insensitive to beta-lactamase (also known as penicillinase) enzymes secreted by many penicillin-resistant bacteria. The presence of the ortho-dimethoxyphenyl group directly attached to the side-chain carbonyl group of the penicillin nucleus facilitates the β-lactamase resistance, since those enzymes are relatively intolerant of side-chain steric hindrance. Thus, it is able to bind to penicillin-binding proteins (PBPs) and inhibit peptidoglycan crosslinking, but it is not bound by or inactivated by β-lactamases.
Methicillin is no longer used to treat patients. Compared to other beta-lactamase-resistant penicillins, it is less active, can be administered only parenterally, and has a higher frequency of interstitial nephritis, an otherwise-rare side-effect of penicillins. But it serves a purpose in the laboratory to determine the antibiotic sensitivity of Staphylococcus aureus to other beta-lactamase-resistant penicillins.
| Wikinews has related news: Supergerm deaths soar, surpass AIDS in the United States |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)